Day: January 19, 2024

– 10,000-subject Phase 2b study would evaluate Vaxart’s next generation oral pill XBB COVID-19 vaccine against an approved mRNA vaccine comparator – – Project NextGen is a $5 billion initiative by the U.S. Department of Health and Human Services to develop innovative vaccines and therapeutics providing broader and more durable protection for COVID-19 – SOUTH SAN FRANCISCO, Calif., Jan. 19, 2024 (GLOBE NEWSWIRE) — Vaxart, Inc. (Nasdaq: VXRT) today announced that the United States Biomedical Advanced Research and Development Authority (BARDA) has awarded the Company $9.27 million to fund preparation for a 10,000 subject Phase 2b clinical study evaluating Vaxart’s oral pill XBB COVID-19 vaccine candidate against an approved mRNA vaccine comparator. “We are very honored to receive this BARDA award, which will...

Long-term partnership to help Safety Shot drive brand awareness and significant revenue quickly JUPITER, FL, Jan. 19, 2024 (GLOBE NEWSWIRE) — Safety Shot, Inc. (Nasdaq: SHOT) today announced that Steve Deleonardis, SteveWillDoIt, is partnering with the Company to promote Safety Shot, the first patented wellness beverage on Earth that helps people feel better faster by reducing blood alcohol content, boosting mental clarity and mood. SteveWillDoIt has millions of followers and billions of views across YouTube, Instagram, TikTok, X, and Snapchat. As a social media influencer and content creator, Steve is known for his challenge videos, philanthropy, and high-profile collaborations with world-renown personalities. Safety Shot will be featured in SteveWillDoIt’s lifestyle content across social media platforms, integrated into high-impact...

ATHENS, Greece, Jan. 19, 2024 (GLOBE NEWSWIRE) — C3is Inc. (Nasdaq: CISS) (the “Company”), a ship-owning company providing dry bulk and crude oil tanker seaborne transportation services, today announced the pricing of a firm commitment underwritten public offering with gross proceeds to the Company expected to be approximately $7.0 million, before deducting underwriting discounts and other estimated expenses payable by the Company. The offering was upsized from $6.0 Million. The offering consists of 28,000,000 Common Units or Pre-funded Units, each consisting of one share of common stock (“Common Share”) or Pre-Funded Warrant, one half of a Class B-1 Warrant to purchase one Common Share at an exercise price of $0.375 per share (or 150% of the price of each Common Unit sold in the offering) or pursuant to an alternative cashless...

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Jan. 19, 2024 (GLOBE NEWSWIRE) — G2 Goldfields Inc. (“G2” or the “Company”) (TSXV:GTWO, OTCQX:GUYGF) is pleased to announce that it has closed the previously announced strategic investment by AngloGold Ashanti plc (“AGA”) of 24,500,000 common shares of the Company (the “Shares”) at a price of $0.90 per Share for aggregate gross proceeds of $22,050,000 (the “Strategic Investment”). The net proceeds from the Strategic Investment are expected to be used to advance exploration activities at the Company’s Oko project in Guyana and for working capital and general corporate purposes. In connection with the Strategic Investment, the Company and AGA entered into an investor rights agreement pursuant to which AGA was granted pre-emptive and top-up...

TAMPA, Fla., Jan. 19, 2024 (GLOBE NEWSWIRE) — Kforce Inc. (NASDAQ: KFRC), a provider of professional staffing services and solutions, today announced that Kforce management will participate in the Barclays Industrial Select Conference on February 22, 2024, in Miami. Kforce’s investor presentation can be accessed on our website at www.kforce.com in the Investor Relations section under “News and Events.” About Kforce Inc.Kforce is a solutions firm specializing in technology and other professional staffing services. Each year, we provide career opportunities for approximately 20,000 highly skilled professionals on a temporary, consulting or direct-hire basis. These professionals work with approximately 2,500 clients, including a significant majority of the Fortune 500, helping them conquer challenges and meet their digital transformation...

SASKATOON, Saskatchewan, Jan. 19, 2024 (GLOBE NEWSWIRE) — IsoEnergy Ltd. (“IsoEnergy” or the “Company”) (TSXV: ISO; OTCQX: ISENF) is pleased to announce that it has entered into an amended agreement with Eight Capital, as co-lead underwriter and joint bookrunner on behalf a syndicate of underwriters (collectively, the “Underwriters”), including Haywood Securities Inc., as co-lead underwriter and joint bookrunner, pursuant to which the Underwriters will now purchase for resale, on a “bought deal” basis, 3,200,000 federal flow-through common shares of the Company (the “Premium FT Shares”) at an offer price of C$6.25 per Premium FT Share (the “Issue Price”), for aggregate gross proceeds of C$20,000,000 (the “Offering”). The Company has granted the Underwriters an option to purchase for resale up to an additional 15% of the Premium...

MESQUITE, NV, Jan. 19, 2024 (GLOBE NEWSWIRE) — via NewMediaWire – United Health Products (UEEC) reports today on the receipt and review of final reports on product sterilization and stability testing for its hemostatic gauze. As previously disclosed, UHP has been working with external packaging and sterilization service providers to complete various required tests for its Premarket Approval application. The reported data received this week on the efficacy of the proposed radiation sterilization protocol were well within acceptable bioburden levels for Class III products. UHP will now compile these data and proceed with final drafting of the PMA documentation to be submitted via the eSTAR platform for FDA and Health Canada review. There can be no assurance that the company’s PMA or Health Canada applications will be approved. About...